Highly Sensitive Lineage Discrimination of SARS-CoV-2 Variants through Allele-Specific Probe PCR

Author:

Ratcliff Jeremy1ORCID,Al-Beidh Farah23,Bibi Sagida4,Bonsall David5ORCID,Costa Clemens Sue Ann46,Estcourt Lise78,Evans Amy8,Fish Matthew91011,Folegatti Pedro M.12,Gordon Anthony C.23,Jay Cecilia1ORCID,Jennings Aislinn91011,Laing Emma8,Lambe Teresa12,MacIntyre-Cockett George5,Menon David13,Mouncey Paul R.14,Nguyen Dung1,Pollard Andrew J.415,Ramasamy Maheshi N.416,Roberts David J.717,Rowan Kathryn M.14,Rynne Jennifer91011,Shankar-Hari Manu91011ORCID,Williams Sarah116,Harvala Heli18,Golubchik Tanya5ORCID,Simmonds Peter1ORCID

Affiliation:

1. Peter Medawar Building for Pathogen Research, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

2. Imperial College London, London, United Kingdom

3. Imperial College Health NHS Trust, St. Mary’s Hospital, London, United Kingdom

4. Oxford Vaccine Group, Department of Paediatrics, University of Oxford, Oxford, United Kingdom

5. Big Data Institute, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom

6. Institute for Global Health, University of Siena, Siena, Italy

7. Haematology Theme, Radcliffe Department of Medicine, University of Oxford, Oxford, United Kingdom

8. Clinical Trials Unit, NHS Blood and Transport, Oxford, United Kingdom

9. School of Immunology and Microbial Sciences, Kings College London, London, United Kingdom

10. Guy’s and St. Thomas’ NHS Foundation Trust, St. Thomas’ Hospital, London, United Kingdom

11. Centre for Inflammation Research, The University of Edinburgh, Edinburgh, United Kingdom

12. Centre for Clinical Vaccinology and Tropical Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom

13. University Division of Anaesthesia, University of Cambridge, Cambridge, United Kingdom

14. Intensive Care National Audit and Research Centre, London, United Kingdom

15. NIHR Oxford Biomedical Research Centre, Oxford, United Kingdom

16. Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom

17. Clinical, Research, and Development, NHS Blood and Transport, Oxford, United Kingdom

18. Microbiology Services, NHS Blood and Transport, London, United Kingdom

Abstract

Tools to detect SARS-CoV-2 variants of concern and track the ongoing evolution of the virus are necessary to support public health efforts and the design and evaluation of novel COVID-19 therapeutics and vaccines. Although next-generation sequencing (NGS) has been adopted as the gold standard method for discriminating SARS-CoV-2 lineages, alternative methods may be required when processing samples with low viral loads or low RNA quality.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Reference29 articles.

Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3